Compare LMAT & BSTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LMAT | BSTZ |
|---|---|---|
| Founded | 1983 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.1B |
| IPO Year | 2006 | N/A |
| Metric | LMAT | BSTZ |
|---|---|---|
| Price | $80.58 | $29.60 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $105.80 | N/A |
| AVG Volume (30 Days) | ★ 210.0K | 159.3K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | 0.93% | ★ 8.31% |
| EPS Growth | ★ 30.57 | N/A |
| EPS | ★ 1.42 | 0.71 |
| Revenue | ★ $249,602,000.00 | N/A |
| Revenue This Year | $14.21 | N/A |
| Revenue Next Year | $8.88 | N/A |
| P/E Ratio | $57.03 | ★ $42.14 |
| Revenue Growth | ★ 13.53 | N/A |
| 52 Week Low | $78.22 | $20.69 |
| 52 Week High | $118.01 | $31.89 |
| Indicator | LMAT | BSTZ |
|---|---|---|
| Relative Strength Index (RSI) | 45.15 | N/A |
| Support Level | $78.65 | N/A |
| Resistance Level | $82.45 | N/A |
| Average True Range (ATR) | 1.59 | 0.00 |
| MACD | 0.55 | 0.00 |
| Stochastic Oscillator | 51.13 | 0.00 |
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
BlackRock Science and Technology Trust II is a diversified, closed-end management investment company. Its investment objectives are to provide total return and income mainly through long-term capital appreciation. The Trust invests a majority of its total assets in equity securities issued by U.S. and non-U.S. science and technology companies in any market capitalization range, selected for their rapid and sustainable growth potential from the development, advancement, and use of science and/or technology. Its investment portfolio comprises securities of companies from various industries, such as semiconductors and semiconductor equipment, software, communications equipment, IT services, and entertainment, etc.